Metabio’s advanced, patent pending, solutions provide the platform for Biobanks to work independently or in interoperable networks; as they function seamlessly alongside existing systems. Our versatile platform e-MetaBank® collects, stores and sources longitudinal data from the biosample usage chain, from the donor to the researcher, providing added value services. e-Metabio®, harmonizes your data from every source to an HL7 specification for Healthcare Interoperability using FHIR-Fast Health Interoperability Resources; offer donors a dynamic real time e-consent for managing donation status; allow your partners to perform real-time multicriteria queries and get instant availability reports with percentage cluster adoption.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Agisilaou,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- metab.io
- Keywords
- biobanking, precisionmedicine, biosamples, digitalbioanking, biospecimens, personalize, data management, e-consent.
- HQ
- Thessaloniki, Central Macedonia
Metabio Questions
Metabio's website is metab.io
Metabio's LinkedIn profile is https://www.linkedin.com/company/metabio
Metabio has
8 employees.
View email and phone details for 8
employees at Metabio.
Metabio's industry is
Biotechnology Research
Metabio's top competitors are
Deeppath,
Atg - Access To Genome,
Kos Biotechnology Partners,
Metabio,
Bioanalytica S.a.,
Metabion,
Eurogenetica,
Pfizer,
Fertlab - Τράπεζα Κρυοσυντήρησης | Κέντρο Διερεύνησης Γονιμότητας,
Dnasequence Srl.
Metabio's categories are Biotechnology Research
Metabio's founding year is 2018
